This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Early Aggressive Strategy for Treatment of Lipid-Lowering in Acute Ischemic Stroke Delivered With Endovascular Therapy for Large Artery Occlusion | MicrobiomeTrials
← Back to trials NCT07002476
Early Aggressive Strategy for Treatment of Lipid-Lowering in Acute Ischemic Stroke Delivered With Endovascular Therapy for Large Artery Occlusion Recruiting PHASE3 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2025-06-19Est. Completion: 2027-03-01
Enrollment target: 978 participantsLocations Shanghai East Hospital, Tongji University, Shanghai, China Other microbiome trials you might be interested in Ischemic Stroke
In 2015, five randomized trials showed efficacy of endovascular thrombectomy over standard medical care in patients with…
Shenyang, China Est. completion Jun 30, 2028
Upper Limb Motor Dysfunction Stroke Incomplete Spinal Cord Injury Traumatic Brain Injury Upper Limb Orthopedic Trauma
The goal of this pilot randomized controlled trial is to learn whether the ZEPU-SG1PLUS Hand Functional Comprehensive Tr…
Dhaka, Bangladesh Est. completion Sep 2026
Chronic post-stroke hemiplegia frequently results in persistent motor deficits, impaired balance, and reduced quality of…
Multiple Locations Est. completion Oct 15, 2026